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FIVE-YEAR INTEGRATED INITIAL EDUCATION PROGRAMME FOR 
PHARMACISTS IN SCOTLAND 
SCOPING REPORT 
Introduction 
In response to the vision for pharmaceutical care in Scotland, the Programme for 
Government commitments and current and future workforce developments, the 
Cabinet Secretary for Health and Sport, through the auspices of the Chief 
Pharmaceutical Officer (CPO), established an Advisory Group to explore the 
evolution of the existing pharmacist four-year undergraduate degree and the one-
year pre-registration (4+1) training scheme into an integrated five-year programme to 
support the initial education of pharmacists in Scotland. 
The initial education and training of a pharmacist comprises a four-year Master of 
Pharmacy (MPharm) degree and a one-year pre-registration training programme. 
The two Higher Education Institutions (HEIs) in Scotland who offer an MPharm are 
the School of Pharmacy and Life Sciences at Robert Gordon University (RGU) in 
Aberdeen and Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) 
at Strathclyde University in Glasgow.  This is followed by 52-week pre-registration 
training programme which, in Scotland, is a national professional training year 
managed by NHS Education for Scotland (NES).  Pre-registration trainees then have 
to pass a national registration assessment and health and good character checks 
before registering as a pharmacist.   
Pharmacy undergraduate and pre-registration education and training in Scotland is 
highly regarded across the UK and the Schools of Pharmacy, NES and the General 
Pharmaceutical Council (GPhC) have continued to develop and improve aspects of 
both undergraduate and pre-registration training. However, there is an emerging 
view about the need for a stepped change to evolve to a more clinically focused 
integrated education programme in order to ensure the competencies and qualities 
of future graduates meet the workforce demands in Scotland.  This includes 
delivering enhanced experiential learning in clinical practice and recognising the 
value of workplace learning for reinforcing confidence and competence.  It also 
provides opportunities for earlier development and assessment of professionalism, 
holistic clinical decision-making and consultation and clinical assessment skills.  
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This report describes the outputs from the initial scoping exercise undertaken by the 
Advisory Group and provides a background context, as well as the drivers for 
change, to the current arrangements. The report outlines work undertaken during the 
scoping exercise and the outcome of engagement with a range of stakeholders 
including the NHS and staff and students at the two Scottish Schools of Pharmacy. 
The Advisory Group also considered evidence from both the medical and nursing 
professions as well as from the School of Pharmacy at the University of Nottingham 
in order to assimilate lessons that could be learnt from other professions and pilots.    
Recommendation 
The consensus view from the Advisory Group was to recommend progressing to a 
five-year integrated initial education programme for pharmacists in Scotland.  It was 
the view of the Group that this recommendation provided opportunities to better 
prepare new pharmacists for practice in Scotland and permitted better management 
of pharmacy trainee numbers to meet workforce demands both in terms of initial 
recruitment and on-going progression. This, in turn, supported Ministerial priorities to 
strengthen the clinical workforce, especially in primary care.  It also supports the 
development of the pharmacy profession towards achieving the aim that every GP 
practice will have access to a pharmacist with advanced clinical skills as detailed in 
the recently published Health and Social Care Delivery Plan, by ensuring the new 
generation of pharmacists are able to practice in the evolving NHS health and social 
care landscape.  
The Advisory Group acknowledged that there were a number of different models that 
could be used to provide a platform to deliver the five-year integrated MPharm 
however they did not recommend how an integrated model would be delivered (for 
example a 12 month block in year five; two six month blocks, the later in the final six 
months of year five; or a set of dispersed blocks across the first four years and a final 
six month block at the end of the fifth year).  They agreed that this aspect was better 
worked through as part of the implementation arrangements.    
Advisory Group members also agreed that a Scotland-wide approach to introducing 
a new model was preferable in common with the Once for Scotland approach 
promoted by Scottish Government and the service.  It could also support a regional 
accreditation approach going forward and this would help facilitate that from a 
Scotland perspective.  
Implementation, transition and addressing any associated issues 
In reaching its recommendation the Advisory Group identified a number of issues 
and logistical challenges with regards the journey towards a five-year integrated 
programme which led them to articulate the importance of ensuring a robust 
transition process which should include matters such as resourcing, culture change, 
internationalisation and adequate piloting in order to ensure it is introduced in a 
measured way.  The group agreed that it was imperative that the work was taken 
forward building on the right founding principles, that the benefits of the changes 
were clearly articulated and that all essential preparatory activities were identified 
and translated into effective operational plans and that sufficient piloting was 
included prior to national roll-out.   
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In forming this decision, the following key issues and priorities were considered and 
will form the basis of transitional and implementation arrangements: 
 Funding: deliver within the existing funding envelope and utilise the current
funding arrangements more effectively.
 Numbers: agree and align student/trainee intake numbers including any
flexibility in trainee numbers based on workforce needs to ensure NHS
Scotland is self-sufficient and to provide for a progression based on merit.
 Attributes: ensure suitable attribute and qualities to meet workforce demands.
 Admissions: develop a standardised admissions process centred on values-
based recruitment and including multiple mini-interviews.
 Experiential learning: increase experiential learning in the undergraduate
programmes to support preparation for practice. Embed clinical decision-
making and clinical assessment skills in the undergraduate MPharm. Increase
interprofessional learning.
 Training providers: increase the range of training providers utilised for both
MPharm experiential learning placements and pre-registration training, and
provide a quality management framework to ensure effective support. Ensure
the service supports experiential learning across hospital, community
pharmacy and primary care.
 Quality management: develop the existing quality management processes to
support the new arrangements as they are implemented.
 International students: ensure the model supports the two Schools of
Pharmacy to maintain and manage international students.
Implementation outline 
It is proposed that the new five-year integrated initial education programme for 
pharmacists in Scotland could commence implementation from 2020-2021. The aim 
would be for the programme to provide coterminus graduation and registration. The 
first students achieving this status could graduate and register in summer 2025. This 
will require an alignment of the reaccreditation of the two Schools of Pharmacy by 
the GPhC who are the pharmacy regulator in Great Britain so that they both occur 
within the same timescale (2019-2020). Between now and the introduction of the 
five-year integrated MPharm an enhanced 4+1 model will provide a transitional 
programme structure. 
This proposal prepares for a managed integration of the 4-year MPharm and 1-year 
pre-registration training programmes, with progress to a fully integrated five-year 
programme determined by agreement with stakeholders and, in particular, students 
already enrolled in MPharm degrees in Scotland. The modular Pre-registration 
Pharmacist Scheme (PRPS) pilot will be rolled out across the transitional period 
providing experience in the three main patient-facing sectors of practice. 
A new funding model will be proposed for the transition period to support both 
trainees and training providers. Alongside this, improvements to the admissions 
process will mean that all students who successfully complete their MPharm during 
the transition period will automatically progress, based on merit, to a NES pre-
registration position.    
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Scottish Government, in collaboration with NES, the service and the two Schools of 
Pharmacy, will advise on student intake numbers and a values-based admissions 
process including multiple mini-interviews will be developed that will include the 
involvement of training providers in the selection of the student intake. The plan is to 
pilot the admissions process in 2018-2019 and roll out from 2019-2020. 
Next steps 
 Agree proposal indicative timescales;
 Sign off transitional arrangements;
 Establish a series of working groups to consider: admissions and recruitment;
funding; programme development (including experiential learning and
interprofessional learning; and quality management and governance;
 Clarify position of international students including visa requirements; and
 Schools of Pharmacy to start planning towards accreditation of a five-year
integrated MPharm.
Pharmacy and Medicines Division 
Directorate of the Chief Medical Officer 
April 2017 
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Background 
The current initial training of pharmacists consists of a four-year Master of Pharmacy 
degree (MPharm) followed by a separate 52-week pre-registration training scheme. 
In Scotland there are two Schools of Pharmacy who offer an MPharm: the School of 
Pharmacy and Life Sciences at Robert Gordon University (RGU) and Strathclyde 
Institute of Pharmacy and Biomedical Sciences (SIPBS) at Strathclyde University. 
The MPharm is a 600 credit integrated Masters Programme, delivered over four 
years, covering SCQF levels 7–11. Students, when they graduate from the course, 
will have the knowledge, skills and behaviours to deliver the very best 
pharmaceutical care for patients, underpinned by sound scientific knowledge and 
principles.  
 The undergraduate MPharm Programme
The overall philosophy at both universities is student-focused and aims to develop a 
pharmacy student to be a life-long learner and reflective practitioner, with an 
emphasis, throughout the course, on interprofessional education and other 
professional experiences. This includes providing some interactions with 
experienced pharmacists, other healthcare professionals, carers and patients, 
although time in clinical practice is limited. In part, this is due to the current Scottish 
Funding Council (SFC) funding model. The SFC provides funding for an MPharm 
undergraduate degree as a science/laboratory-based subject at price group 2 
(£9,336 per FTE), unlike medicine and dentistry, who are funded for two years at 
price group 3 (£8,274 per FTE) and three years at price group 1 (£16,454 per FTE). 
Additional funding for experiential learning and placements for medical and dental 
undergraduate education comes through Additional Cost of Teaching (ACT) funding. 
There is no equivalent for pharmacy meaning that opportunities for patient contact, 
placement and other forms of experiential learning are limited and rely on goodwill 
and personal relationships. On completing the MPharm graduates must undertake a 
pre-registration training year before registering to practise as a pharmacist. The 
MPharm degrees at RGU and SIPBS were accredited by the pharmacy regulator, 
the General Pharmaceutical Council (GPhC), in 2013 and 2014 respectively for the 
maximum period of six years with no conditions or recommendations. This was 
against the GPhC education standards published in 2011, ‘Future Pharmacists; 
Standards for the Initial Education and Training of Pharmacists’, as part of its 
statutory responsibilities in approving qualifications for pharmacists across Great 
Britain.  
 The Pre-registration Training Scheme
The NHS Pre-registration Pharmacist Scheme (PRPS) was established in Scotland 
in 2006 to address identified variations in the quality of training provision and 
assessment in the pre-registration pharmacist training year and to assist in meeting 
the needs of the Scottish Government strategy for pharmaceutical care. NHS 
Education for Scotland (NES) was tasked to organise and manage the overall 
centralisation of the pre-registration education and training year for trainees in both 
hospital and community pharmacy settings across Scotland. The primary objective of 
the scheme was to standardise the training experience for pre-registration trainees in 
Scotland and to provide a quality management system (QM). Currently, 170 PRPS 
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trainees are employed in Scotland by their preferred NES approved Training 
Provider with their salary and associated costs being covered by a training grant paid 
to the employer by NES. 
 Future developments
The GPhC’s Standards document also refers to the desire to increase the clinical 
context of the initial training of registered pharmacists and mentions the potential of a 
five-year integrated degree combining academic study and pre-registration training 
being a future possibility. This reflects some of the recent discussions and proposals 
in England around Modernising Pharmacy Careers (MPC) towards combining the 
undergraduate degree and pre-registration year to lead to a five-year degree 
programme with coterminus graduation and registration. There are currently two 
Schools of Pharmacy in England offering fully integrated five-year degree courses, 
although they are mainly aimed at international students. That said, the GPhC has 
been consistent in recognising that the MPharm degree plus the pre-registration 
training (4+1) model will remain the pre-dominant model in the short term with an 
integrated degree being a future possibility. In addition, the GPhC Standards have 
been written in such a way that they support either model as the regulator has not 
been prescriptive about delivery structures, but instead concentrates on outcomes of 
the education and training processes. 
Drivers for change 
Pharmacy undergraduate and pre-registration education and training in Scotland is 
highly regarded across the UK. However, there is a growing requirement to further 
enhance the initial education and training of pharmacists to meet the developing role 
of the profession and the needs of the NHS in Scotland. In addition, concern has 
been expressed regarding the mismatch of numbers between MPharm graduates 
from the two Schools of Pharmacy and funded PRPS training places and the 
consequent risk to programme standardisation as well as the confidence and 
competence of current newly registered pharmacists to deliver emerging future 
practice models. In addition, there is an argument that other parts of the UK absorb 
some of the current over-production and this may not be sustainable as new 
arrangements are implemented.  
The key driver for any change to the current arrangements for the initial education 
and training of pharmacists has to be rooted in delivering an educational benefit by 
ensuring trainees are fully prepared for practice in Scotland as the implementation of 
Scottish Government policy progresses. In addition, there is robust evidence from 
other clinical professions of the educational benefit in further integration of 
undergraduate education and pre-registration training with enhanced experiential 
learning in clinical practice throughout the period of learning. This also allows earlier 
assessment of professionalism and provides the opportunity to embed the 
development of clinical skills. There is also an opportunity to further align work on 
improving the interprofessional learning (IPL) at undergraduate level between 
Schools of Medicine and Pharmacy with a focus on person-centred care and patient 
safety to ensure shared values support increasingly collaborative models of practice. 
NES Pharmacy has already commissioned the School of Medicine at the University 
of Dundee and the School of Pharmacy and Life Sciences at Robert Gordon 
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University in Aberdeen to appointed a joint Academic IPL Fellow whose role is to 
design, deliver and evaluate IPL between undergraduate medical and pharmacy 
students at both institutions. The first year of the research programme (2014-15) 
involved a mapping of the standards required of undergraduate education for the 
professions regulated by the General Dental Council, General Medical Council, 
General Pharmaceutical Council, Health and Care Professions Council and Nursing 
and Midwifery Council. The mapping has been subsequently used as a framework 
for creating and evaluating IPL pilots which allow for reference back to the regulatory 
standards.    
Another important driver has to be better management of pharmacy trainee numbers 
to meet workforce demands both in terms of initial recruitment and on-going 
progression. This, in turn, supports Ministerial priorities to strengthen the workforce, 
especially in primary care. It also underpins the delivery of the commitment outlined 
in the Health and Social Care Delivery Plan that every GP practice will have access 
to a pharmacist with advanced clinical skills by ensuring the new generation of 
pharmacists are able to practice in the evolving NHS care landscape. Finally, there 
are a number of issues with the current arrangements: the mismatch of 
student/trainee numbers registered for the degree programme and the availability of 
NES PRPS training places available within the service resulting in NES not being 
able to offer a PRPS place to competent students; a growing number of non-funded 
PRPS places which has the potential to impact on quality; and variable 
arrangements for non-funded places which were based on an agreement between 
the trainee and training provider and with the consequences that students may get 
paid an equivalent salary, they may get paid less, they may not get paid at all or they 
may be asked to pay the training provider. 
Comparison with the rest of the UK 
Health Education England (HEE) has been working for the last ten years towards 
reforming pharmacists’ initial education through the Modernising Pharmacy Careers 
(MPC) Programme with the aim of introducing an integrated five year model. As an 
interim measure HEE are developing proposals to introduce an enhanced workplace 
based education infrastructure to support delivery of the pre-registration year in its 
current format. This will include changes to the recruitment and selection of pre-
registration pharmacists with the aim of increasing the principles of values based 
recruitment across all funded pre-registration pharmacist posts, similar to the NES 
PRPS scheme. Wales and Northern Ireland have also started exploring the 
introduction of integrated five year programmes along similar lines.  
Scoping Project 
The purpose of the scoping project was to consider and agree a work plan for an 
integrated five year programme to support the initial education of pharmacists in 
Scotland through engagement with stakeholders to determine the issues to be 
addressed and the possible options for integration. 
A Scottish Government Pharmacy Initial Education and Training Advisory Group was 
established to enable initial discussion and provide oversight of initial and on-going 
progress with the scoping project. It included representation from all key 
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stakeholders including the two Schools of Pharmacy, NES, Scottish Government 
(workforce), NHS Board Directors of Pharmacy, Community Pharmacy Scotland 
(CPS), Royal Pharmaceutical Society (RPS), and the GPhC (see Appendix 1).  
The remit of the Advisory Group was to consider and agree a work plan for an 
integrated five year programme to support the initial education of pharmacists in 
Scotland (see Appendix 2). A work plan was prepared and agreed by the Advisory 
Group (see Appendix 3). 
Beyond the Advisory Group, a Stakeholder Engagement Event was organised to 
permit discussion with a broader range of individuals and organisations, together 
with meetings with staff and students at both Scottish Schools of Pharmacy. The 
focus of these events was on the key issues to be addressed and consideration of 
model options. All stakeholders were invited to consider the key issues and the 
following three broad options for programme structure:  
Option 1: Maintain separate qualifications (4-year MPharm followed by 
application for 1-year pre-registration training).  
Option 2: Move to a linked qualification (4-year MPharm progressing to 1-year 
pre-registration training). 
Option 3: Introduce an integrated qualification (five-year programme with 
coterminus graduation and registration). 
Advisory Group: Meeting One 
The first meeting of the Advisory Group provided an opportunity to reflect on the 
current situation and to consider some of the high level issues from the perspective 
of each stakeholder group member. The two Schools and NES provided an overview 
of their current programmes and some of the opportunities and challenges. The 
GPhC stated its commitment to devolution and supporting multiple delivery models 
across GB. The group highlighted issues including: non-funded places and the 
implications for NHS Boards, aspirations of students and early career pharmacists 
with regards generalists and specialist roles and skills, lack of placement and 
experiential learning in the undergraduate courses, service demands especially in 
primary care, managing application and numbers and the lack of robust pharmacy 
workforce data. The group also discussed admission processes, the management of 
graduate entry and the importance of international students to the viability of the 
degree programmes. It was acknowledged that these key challenges sat against a 
backdrop of transformational change in terms of primary care and community health 
services, health and social care integration, the priorities identified through Realistic 
Medicine and the demand for clinical pharmacy input to general practice. To assist 
with further discussion, the Group undertook to gather information on how early 
years’ education and training was managed in other healthcare professions.   
Advisory Group: Meeting Two 
The Advisory Group received presentations on nursing and medical models for 
workforce planning, placements and experiential learning. 
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 Nursing: Dr Colette Ferguson and Dr Peter Ward
The presentation described the nursing and midwifery performance management 
system used by NES. The Nursing and Midwifery Council (NMC) are the regulatory 
body who set the education standards which shape the content and design of 
programmes and state the competences of a nurse and midwife. They also approve 
education institutions and programmes and maintain a database of approved 
programmes, including quality assurance. The standards for learning and 
assessment in practice are implemented as a collaboration between the universities 
and the service. There are a regulated number of hours, and nursing students spend 
approximately 50% of their time in practice orientated placements. The degree 
programmes can be three of four years in length.  
Student intake targets are set annually through a collaborative process involving 
Scottish Government, the Executive Nursing Director, the Universities, the SFC, 
NES, the Care Home sector and associated partnerships. Decision making is based 
on demand, supply, recruiter’s net data, workforce profiling and professional 
judgment. The majority of students in a nursing degree programme are home 
students and the number of overseas students is very small. Performance 
management is conducted by NES on behalf of Scottish Government by monitoring 
the progression and completion data for all providers. This includes monitoring the 
performance within and between universities and advising on likely future outputs 
and optimum intake targets. 
The data sources used in the performance management system were described. 
They included: recruitment and retention data and annual students and mentor 
surveys. Surveys include an annual final year survey and take into account overall 
satisfaction, clinical decision making and clinical practice. Quality Management of the 
Practice Learning Environment (QMPLE) is an online database that has been 
developed by NES in partnership with colleagues from both practice and 
universities.  It manages information relating to the quality of the practice learning 
experience through student feedback, educational audits, quality standards for 
practice placement (QSPP) audits and mentorship data. QMPLE is a tool designed 
for and used in practice but it also is available to universities and provides accessible 
and meaningful feedback on areas including placement information. 
Mentorship is a very important element to the programme as is partnership and the 
NMC look for evidence of partnership. There are service level agreements (SLAs) in 
place for the number and quality of placements. Overall there was agreement that 
the focus on practice educators, mentorship and the underpinning infrastructure 
seemed critical to the success of the programme.  
 Medicine: Professor Gary Mires
The presentation described the move to outcomes based education at the School of 
Medicine at the University of Dundee; the use of technology and small group 
learning in teaching; assessment processes tailored to the curriculum needs; and the 
student selection process. 
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With regards the outcomes based approach the aim was to define the product and 
then design the curriculum. The Dundee graduate is expected to be able to practice 
as a safe and reflective doctor and have the capability to enter postgraduate training. 
The focus of teaching and learning throughout all five years of the Dundee 
undergraduate medical degree is based on over 100 core clinical problems, with 
students building on defining the diseases that can contribute to these core 
problems. Years one to three are based around (body) systems in practice and years 
four and five on preparation in practice. In other words, students start in the early 
years with basic practice linked to body systems-based learning and there is a 
transition to clinical practice in the later years with increasing clinical attachments. 
Students learn to identify normal and abnormal. There is a strong emphasis on 
integrating science and specialties, with a focus on the patient rather than the 
system. Years four and five are focused on the transition into clinical practice with all 
the systems based teaching pulled together. There are a number of core clinical 
placements: medicine, surgery, obstetrics and gynaecology, child health, psychiatry 
and general practice along with a student selected clinical component (SSC). The 
fifth year is basically providing a probation period for practice (Dundee call it a 
foundation apprenticeship).  
Technology is used to enhance student learning. Strategies include an interactive 
virtual learning environment (VLE), simulation, eLearning, team based learning and 
virtual patients. Technology underpins all teaching activities. In addition, the 
timetable links to learning resources. Medical students see patients from week two of 
year one of the programme. They undertake most of their learning in years one to 
three in small group problem-orientated teaching activities. Integration is the key: the 
basic science runs throughout the medical undergraduate programme; it is the 
emphasis that changes. In years four and five the blocks link to specific disciplines 
with students moving around the clinical environment however core clinical problem 
solving remains a key part of the learning. Students also build a portfolio of evidence 
using the NES portfolio which links to post-graduate training. In year five the 
emphasis changes and students are prepared for practice as a Foundation Year 
(FY) doctor: Foundation Apprenticeship with the FY doctors providing supervision. 
They are embedded in the ward environment and undertake shadowing of FY 
doctors. They are expected to develop a learning plan and are actively engaged in 
case load management (working with FY doctors). Students work in interprofessional 
teams. There is a mid-point review in the fifth year, followed by developing a 
reflective diary, formative work placed based assessment and a final review.  
Reflecting on the presentations the group noted the access to patients for students 
provided through the approaches in medicine and nursing and the relative paucity of 
clinical placements in the pharmacy undergraduate course compared to the nursing 
and medical courses which can be a matter of days in pharmacy compared to weeks 
and months for the other professions. There was discussion on the Additional Cost 
of Teaching (ACT) funding provided by the Scottish Government to cover the 
additional costs of teaching medical undergraduate students within the NHS. NES 
distributes ACT fund to all NHS Boards and GPs in Scotland who are engaged in 
undergraduate teaching. NHS Boards are responsible for delivery of clinical teaching 
to undergraduate medical students and for ensuring appropriate quality standards 
are met within local education providers. A performance management framework 
supports the management of Medical ACT and all Boards have to meet the 
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requirements to receive Medical ACT funding. ACT funding was seen as a great 
success story due to the fact that it allows for investment at NHS Board level to 
support the use of NHS staff to teach medical students as part of their under-
graduate education.  
NHS Stakeholder Event 
The NHS Stakeholder Event provided the opportunity to glean the views on a five 
year integrated initial education programme for pharmacists of a wide range of 
individuals and organisations involved in aspects of leadership, pre-registration 
training and/or postgraduate pharmacy education. Participants received 
presentations from the service providers, Schools of Pharmacy and NES on the 
current situation and were invited to discuss the key issues and options for change. 
The presentations highlighted the following key issues:  
 Service: needs of the service for a different type of pharmacist practitioner;
and support for increased experiential training;
 Schools of Pharmacy: limited experiential training and IPL; SFC
arrangements; and the number of graduates produced from the two Schools
is much higher than the available training places making Scotland a net
exporter of students and not benefitting the Scottish workforce;
 PRPS: well-respected UK scheme with robust recruitment, consistent training
and rigorous QM monitoring with a memorandum of understanding (MoU) with
GPhC; only 170 training places currently; no workforce planning; an
increasing number of non-funded places (30) with limited input and QM; and
the modular programme offers experience in all sectors and produces more
rounded pharmacists.
The following is a summary of the themes that were identified as a result of the 
subsequent workshop discussions. 
There was consensus from all groups that the status quo was not an option with 
unanimous disquiet on the 'shame' associated with a situation where a pharmacy 
graduate from a Scottish School of Pharmacy cannot access a funded pre-
registration position in Scotland. A compelling reason to change was to provide all 
pharmacy students from the two Scottish Schools of Pharmacy with the opportunity 
of a funded pre-registration place in Scotland.  
Currently the two Scottish schools are in the minority in that they make offers based 
on academic grade predictions alone, unlike most other schools of pharmacy across 
GB who have more extensive admissions processes. There was consensus on the 
introduction of a more robust admissions process with a preference towards 
interviews as a way of ensuring selection of students with the appropriate values and 
behaviours.   
There was broad agreement on the value of increasing experiential learning. The 
requirement to increase the experiential learning at undergraduate level was 
common to all discussion groups with a view from some that placements were critical 
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in order to underpin the context of the students learning and that leaving that to the 
equivalent of a pre-registration year to do so was too late.  
Representatives of the service were clear on the need for a different type of 
practitioner with enhanced clinical decision-making and consultation skills for future 
pharmacy practice. They also recognised their responsibility to support increased 
experiential training.  
The service had very strong views on the importance of interprofessional learning 
(IPL) throughout the pharmacy course and the need for pharmacists to be competent 
and confident working in the multi-disciplinary team. The focus needed to include all 
care settings, including health and social care.   
The Schools of Pharmacy expressed concern that the introduction of a five-year fully 
integrated programme would impact significantly on the attraction of the MPharm 
course to international students who were essential to ensure the financial viability of 
the courses. The Schools were also adamant on the need to maintain their own 
unique individual identities. 
There was a view that funding was critical to providing the time and capacity as 
training provider goodwill was at the limit. The current SFC funding model limits 
access to additional funding. All of the current PRPS funding is used for trainee 
salaries. 
With regard to the options for programme structure, whilst there were views 
expressing support for a fully integrated five-year programme with coterminus 
graduation and registration, the general consensus was a preference to aim for an 
enhanced ‘4+1’ model as an initial step. Advantages and disadvantages of both were 
recognised with the former being challenging for the service to deliver in terms of 
capacity especially in hospital but providing a more flexible model with student 
placements phased across years. Some participants shared concerns about the 
logistics of distributing elective modules during the course. Countering that was the 
argument that if this was a vocational course then experiential learning needed to be 
integrated and embedded throughout. NES had been developing a modular pre-
registration programme offering experience in each sector of practice. There was 
some concern expressed about whether a more modular arrangement reduced the 
ability for employers to recruit to their sector however on the other hand others felt it 
allowed a particular sector to raise its profile with future employees and therefore 
help address recruitment. The GPhC confirmed that as long as the learning 
outcomes were met and the final six-month period of learning in practice was 
maintained then there would not be a problem with any of the proposed options from 
their perspective. The GPhC also indicated their willingness to support any 
transitional programme structure.   
The discussion triggered a number of questions which were collated for further 
feedback from event participants. These questions were also used to structure the 
discussion at staff and student meetings held at both Schools of Pharmacy. 
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Meeting with University of Strathclyde staff and students 
Staff and students were presented with an overview of the key issues and options for 
change and were invited to consider these as well as the questions arising from the 
Stakeholder Event.  
 Students
Students stated a preference for a more clinical focus to any experiential learning 
and for an increase in focus on hospital and primary care opportunities. The students 
also valued the strong science component that runs through the course. They also 
appreciated that IPL was important because they would be working with other 
professions during their careers. 
The students could see how having periods of experiential learning at different 
places in the course would help them apply their learning in practice. They also could 
see how the final six months in practice would help them consolidate their learning 
and prepare for the exam. However they also wanted appropriate quality 
management arrangements.  
Students described the pain associated with the uncertainty of applying for pre-
registration places. They supported an integrated five year programme with 
progression to a fifth year on merit as long as there continued to be appropriate 
incentives for progression (students who work hard and can demonstrate this should 
not be disadvantaged by those who think they can just coast through barely passing 
with minimal effort because there is a guaranteed pre-registration place.) 
Students wanted reassurances over the financial implications but would be prepared 
to sacrifice the current pre-registration salary for a fairer system.  
The students did feel that interviews might help manage the numbers entering into 
the MPharm course and also encourage the selection of the best candidates. 
 Staff
Staff expressed concern that the benefits of a recent course re-design had not been 
seen as there had been no graduates from the revised course as yet. They were 
also concerned about the financial implications for students and the ease of any 
change. Staff sought direction on the skills gap and how this impacts on programme 
content. They were keen on interviews as part of the admissions process. 
Advisory Group: Meeting Three 
The group received a presentation from the University of Nottingham regarding their 
experience of implementing a five-year integrated MPharm.  
University of Nottingham: Tom Gray 
The presentation described the structure and delivery of their five-year course which 
was a fully integrated degree focused on science, practice, placements and IPL. The 
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course had commenced with international students only and their first cohort of ten 
students was due to graduate in July 2017. The drivers and priorities included the 
NHS workforce and its demand for demonstrable knowledge, skills, values and 
behaviours (pharmacists who were professional, flexible, capable and adaptable) 
and the ambition for patient-centred care recognising multi-professional working 
across traditional boundaries. Nottingham introduced multiple-mini interviews (MMIs) 
in 2013 to help recruit students with academic ability as well as appropriate attributes 
for professional practice.  
They had opted for the five-year integrated model because there was strong 
evidence on the value of experiential learning in reflective learning and practice  
in a spiral curriculum. EL started from year one, but the real value came from  
proper placement periods to ensure meaningful, insightful, appreciation of good 
interprofessional working; students moved from individual to group to team 
approaches. On years four and five the focus was on professional socialisation: 
role modelling, reflection, formative and developmental.  
The Advisory Group was in agreement that the key issues on why things needed to 
change had been clearly identified and argued, and there was now a need to 
consider a proposal for change in order that the practical implications for all 
stakeholders could be considered. Key issues included: the needs of the service and 
areas for improvement including admission processes and experiential learning; the 
student numbers; the finances; the longer term implications of improved workforce 
planning data; and the general direction of travel for the NHS. The group needed to 
take into account the emerging role of the pharmacist, how many were needed and 
then how undergraduate (and postgraduate) education best supported those 
requirements.  
There was a clear view across the group that the status quo wasn't an option. It was 
agreed to remove the status quo option leaving both the enhanced 4+1 or five-year 
integrated models be progressed. The group acknowledged the challenges 
associated with changing culture, and that academic processes and changes to the 
academic year that would be at odds with their academic institutions would require 
agreement from the senior management at the universities.  
Meeting with staff and students – Robert Gordon University 
Staff and students were presented with an overview of the key issues and options for 
change and were invited to consider these as well as the questions arising from the 
Stakeholder Event.  
 Students
The main issue for the students was being in a position to complete the five years on 
merit without the risk of being unable to secure a pre-registration post. They thought 
the consequent reduction in stress levels was very important. The students wanted 
the assurance that they would complete the five years if they merited it academically. 
The affordability or cost of the model to the students was the other issue and 
whether they could afford it. Concerns expressed included: if salaries were reduced 
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would there be a guarantee of more training places; would students be able to 
support themselves during the five-year programme, particularly if there were more 
experiential learning placements; geographical issues including accommodation and 
travel costs if experiential learning was not in the vicinity of home or university.  
The students saw benefits with respect to both proposed models however their 
consensus was a preference for the five-year integrated degree, especially from the 
international students. There was also support for experiential learning to be 
dispersed throughout the programme, although they wanted it ‘weighted’ towards the 
end of the programme so that students had the knowledge base to make the most of 
them. There was discussion and agreement on the benefits of following up lecture 
material with experiential learning in practice providing an opportunity to apply the 
learning in practice. There was some concern expressed, however, about 
assessments of the student being made too early in the course if the experiential 
placements included an assessment process. 
There was widespread support for increasing IPL in the programme as long as it was 
done properly i.e. a practical exercise (like a simulation lab, working with other 
professions) not simply being lectured to with other professional groups. 
Students saw interviews as an important element of selection. 
 Staff
Overall the staff view was that with the increasingly elderly population, multi-
morbidities and polypharmacy implications, alongside the need to provide services to 
both urban and rural populations there had never been a greater opportunity for 
pharmacists to play a role, for example the latest commitment to ensure every GP 
practice has access to a pharmacist input. There was re-assurance on the continued 
recognition of the value in the integration of science and practice: it was important 
not to lose sight of the linkage and not too squeeze the science. The integration 
allowed the focus to move to applied science. One participant summed things up in 
saying that given the levels of student dissatisfaction with the current system then 
this was the right time to review things and being able to expose them to mixed 
environments was a positive development.  
Advisory Group: Meeting Four 
A paper describing the two options for change, an enhanced 4+1 or a five-year 
integrated programme, was presented, and the group were asked to consider their 
preferred position.  
It was recognised that some aspects of this could progress without a national 
position. Examples included areas such as the admission process and the modular 
pre-registration programme. 
It was agreed that the proposal must be explicit about balancing the numbers and 
not over-producing pharmacy graduates. 
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It was suggested that the enhanced 4+1 model could be modified in order to badge it 
as a five-year integrated MPharm delivered as a 4+1 model. If the service and the 
Schools were forced to make the links between the undergraduate course and the 
pre-registration year, then it would continue to move the current Scottish model 
forward. The idea would be to keep the traditional concept of a final year at the end 
of the undergraduate course but introduce a linked qualification with coterminous 
registration and graduation. That would allow better control of the numbers and also 
help with the international student dilemma. Consideration would need to be given to 
the status of the students if they exited after four years.  
In essence this would provide three options grouped under a five-year integrated 
model: five-years with a 12-month block; five-years with two six-month blocks; and 
five-years with a dispersed six month block and a final six month block.  
It was agreed that a detailed options appraisal should be prepared for further 
consideration prior to implementation. Following this, there would need to be an 
implementation phase with sufficient time to support any changes.  
Discussion 
The Advisory Group has previously agreed to reject the status quo option (whilst also 
recognising that nothing actually stays the same) and this narrowed the choice down 
to two proposals: an enhanced 4+1 or a five-year integrated programme. Whilst 
funding and student intake numbers were critical the principle decision for the group 
was with regards determining a high level strategic position. Aspects of the detail 
could be addressed as part of any implementation programme. In addition there 
were areas, such as the admission process and the modular pre-registration 
programme, which had been identified during the course of the discussions that 
could progress regardless of any national position.  
 The Problem
Throughout the stakeholder events concerns had been expressed regarding both the 
confidence and competence of current newly registered pharmacists to deliver future 
practice models and the mismatch of numbers between MPharm graduates from the 
two Schools of Pharmacy and funded PRPS training places and the consequent risk 
to programme standardisation.  
 The Student Perspective
Undergraduate students and pre-registration pharmacists supported the idea of 
either a linked 4+1 qualification or an integrated five-year qualification, 
acknowledging that change from the status quo was needed. International students, 
in particular, saw an integrated five-year model not as a barrier but an opportunity to 
gain coterminus graduation and registration as a pharmacist. However, all of them 
stated a preference for the five-year integrated model as long as progression was 
based on performance as a way of maintaining motivation and focus. All groups also 
were prepared to accept a reduced wage or bursary during the equivalent of any pre-
registration training as long as it was enough to live on and that the money saved 
was used to fund additional student places as a result. Importantly they all 
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highlighted that there required to be sufficient Student Awards Agency for Scotland 
(SAAS) funding to support students for five years (including travel and 
accommodation for placements). Again students valued increased experiential 
learning which they believed would increase confidence and competency, and also 
allow students to relate theory to practice. However some had reservations about 
whether a 6-month block at the end of university, as opposed to 12-months, would 
mean they were ready for practice although they conceded that it was difficult to 
judge. There was consensus that increased experiential learning provided more 
options to work in different sectors and opportunities to contextualise their learning 
and apply it in practice. Both undergraduate students and pre-registration 
pharmacists agreed having an interview process at the point of entry to a School of 
Pharmacy was appropriate. The pre-registration pharmacists requested that the 
MPharm be re-classed as a ‘clinical’ degree, thus allowing access to clinical funding 
streams. They were also keen to see an equivalent of ACT funding for pharmacy 
allowing training providers to be remunerated and ensuring standards of quality.  
 The Training Provider Perspective
Both Schools of Pharmacy expressed a desire to ensure that they provided students 
with enhanced experiential learning in clinical practice throughout their period of 
learning accepting the value of workplace learning for reinforcing confidence and 
competence. They also acknowledged the challenges and difficulties when almost all 
their current placement provision was delivered on goodwill. There was a view from 
one of the Schools that as they implemented their redesigned course that it was too 
early to be having a discussion about future changes and that there was little ‘give’ in 
the current programme for any more experiential learning. From a NES perspective 
one of the key challenges is that the student/trainee numbers registered for the 
MPharm degree programmes do not match the current pre-registration training 
places available within the service. Both NES and the two Schools expressed a 
shared interest in ensuring that the competencies and qualities of future pharmacy 
graduates meet the workforce demands in Scotland, albeit that pharmacy workforce 
planning is at a very early stage. They also have a common goal to ensure that all 
changes are developed within a robust clinical and educational governance 
framework. There was also consensus on the value of earlier development and 
assessment of professionalism, holistic clinical decision-making and consultation and 
clinical assessment skills for future pharmacists 
 The Service Provider Perspective
The focus of the service was on ensuring that the competencies and qualities of 
future graduates met the workforce demands in Scotland: newly qualified 
pharmacists practicing at the top of their licence. Service providers articulated that a 
‘day one’ pharmacist should be: capable; confident; comfortable; independent / 
autonomous; able to deliver services; able to recognise their limitations; and be able 
to work with and in the multidisciplinary team, as well as their own team. Whilst 
recognising that the undergraduate MPharm courses were continually changing and 
improving service providers felt progress to date wasn’t enough to drive the step 
change required to build capacity and support the cultural shift required to move the 
profession forward. They saw designing and delivering a new model of enhanced 
experiential learning in clinical practice throughout a five-year model as vital to 
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supporting competence and confidence of early career pharmacists. They were 
looking for all pharmacy graduates to be closer to an Agenda for Change (AfC) 
hospital band 6 than they currently were with an early career educational pathway to 
provide the skills and knowledge to be competent prescribers by early to mid-band 7. 
 The Regulator Perspective
The GPhC remit was driven by the regulatory standards and not workforce planning 
or salary scales (although they remained mindful to the impact of the standards on 
those areas). The GPhC’s focus was currently on integration of science and practice 
and the benefits of this have been evidenced in the student experience. An area for 
future focus will be on interprofessionalism. Currently the GPhC accredit both 4+1 
and integrated five-year courses. There was a clear message that the integrated 
five-year course was here to stay, despite the tensions with the international market 
and associated implications for capacity. The GPhC confirmed that as long as the 
learning outcomes were met and the final six-month period of learning in practice 
was maintained then there would not be a problem with any of the proposed options 
from their perspective. The GPhC also indicated their willingness to support any 
transitional programme structure.   
 The model
The Advisory Group reflected on the purpose of any change. They agreed it was to: 
further enhance the initial education and training of pharmacists to meet the 
developing role of the profession and the needs of the NHS in Scotland; and provide 
better management of pharmacy trainee numbers to meet workforce demands 
balance the numbers in order not to over-produce pharmacy graduates. At the NHS 
stakeholder event there had been a clear statement about it being unethical to 
produce more students than could be accommodated in Scotland and the Advisory 
group agreed that they wanted to address the inequity in access to pre-registration 
places in Scotland. Advisory Group members agreed that the pharmacy workforce 
planning piece of work was at a relatively early stage but there was an opportunity to 
start to address this going forward.  
The GPhC had evidence that the new graduates coming through recently 
reaccredited MPharm courses were seen to be more competent but there was a 
view from the service that further progress was required. When GPhC specifically 
asked the service if enough had been done the answer was no, although they 
acknowledged that they had seen an improvement. The Group heard that the GPhC 
would be rewriting the draft initial education outcomes document that they had 
consulted on in 2013 and that the new outcomes would be a significant step-on from 
the existing ones. As a result, the Group had the opportunity to reflect on the current 
and future needs of the service by considering which model could best 
accommodate the rapidly changing landscape and assist in ensuring future 
pharmacists were equipped with prescribing and clinical skills. Members 
acknowledged the importance of experiential learning and wanted to ensure it was of 
sufficient quality and was provided at appropriate points in the MPharm programme.  
Following on from this, a view was expressed that a commitment to educating the 
future workforce didn't come though as being part of the professional culture in 
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pharmacy. The problem might be that the conversation continually focused on the 
model and not the outcomes. Group members agreed that focusing on achieving the 
outcomes would help the Schools and the service to share ownership of the solution. 
Members agreed that student feedback from the events seemed to indicate that 
being a student for five years was not an issue as far as they were concerned as 
long as there was sufficient funding. They were also struck by the comments from 
students at SIPBS who were in favour of the five-year integrated model but 
concerned about losing their motivation and wanted some process to keep them to 
account (so in one way competition was valued by them). Therefore, there needed to 
be some form of incentive for them to progress.  
The Group discussed the risks and benefits of the different options that had been 
presented. Representatives from the service were concerned about whether an 
enhanced 4+1 model put enough stretch in the system to generate improvement or 
would it ultimately deliver more of the same. There was agreement from a pedagogic 
perspective that all the evidence indicated that a five-year integrated model would be 
the best educational option. This being the case then the next issue was to agree 
where the experiential learning should be provided.  
At the outset of the work the Group had been presented with three options: option 
one which was to maintain separate qualifications (4-year MPharm followed by 
application for 1-year pre-registration training); option two which was to move to a 
linked qualification (4-year MPharm progressing to 1-year pre-registration training); 
and option three which was to introduce an integrated qualification (five-year 
programme with coterminus graduation and registration). Option one had been 
rejected at an earlier stage. The Group considered if there was any mileage in now 
modifying option two to badge it as a five-year integrated MPharm which was 
delivered through an enhanced 4+1 model. In other words, keep the traditional 
concept of a final year at the end of the undergraduate course but introduce a linked 
qualification with coterminous registration and graduation allowing better control of 
the numbers and providing a simple solution to the international student dilemma. 
Consideration would need to be given to a student’s status if they exited after four 
years but that was a conversation that needed to a happen anyway. The advantage 
of this approach was that it forced both the Schools and the service to make the links 
between the undergraduate course and the pre-registration year which would 
continue to move the current Scottish model forward.  
In essence this suggested a five-year integrated model which could be delivered in 
one of three ways: a 12 month block of experiential learning year five; two six month 
blocks of experiential learning the first block to be delivered prior to year five and the 
second in the final six months of year five; or dispersed blocks across the first four 
years and a final six month block at the end of the fifth year. Pharmacy students 
must undertake the final six months in practice as a result of a European Directive.  
The Group had considered the risks and benefits of the different model options 
across the course of their four meetings and had taken evidence from a wide range 
of stakeholders including students and staff. Key themes from the events included: 
ensuring equality; being ambitious; delivering what was needed for the future; better 
mobilising capacity; and supporting culture change. It appeared that the majority of 
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group members were aiming for a five-year integrated MPharm. Members agreed 
that an integrated degree would force the service and the Schools to think about the 
links and bind them together in a shared sense of ownership on delivering the 
outcomes. However in agreeing this, they acknowledged that further work was 
required to bottom out the detail of how experiential learning should be delivered, the 
financing arrangements and how that linked to the admission process, including the 
numbers. There was also a need to ensure stability moving forward so a robust 
implementation plan and a clear transition pathway were seen as critical. It was 
about ensuring the appropriate balance between being ambitious and mitigating 
against risk and ensuring traction versus defining an appropriate pace. This was best 
achieved through a robust transition pathway with incremental steps. The Group 
acknowledged the importance of taking the time needed to prepare the ground for 
any changes, however, if the pace needed to quicken then that was always an 
option. The Group had also identified a number of key building blocks such as the 
current NES modular PRPS pilot, the existing quality management system and 
existing interprofessional learning activities.   
 
 Transitional arrangements 
 
Advisory group members felt that it was important to be clear about the impact of any 
changes. There was a view employers may be reticent to move straight to a five-year 
integrated model. On the other hand perhaps the profession needed to challenge 
itself. It was clear that both the service and students wanted change. By identifying 
areas that would challenge the system and mitigation arrangements to ensure 
against any unintended consequences of change the Group felt robust transitional 
pathway could be put in place to support a decision to move to an integrated five-
year model.  
 
 Experiential learning (EL)  
 
Advisory group members were struck by students’ comments about the variability in 
the quality of undergraduate placements. They identified that ensuring all 
experiential learning, including interprofessional learning, was delivered to an 
excellent standard was an important priority by building on the existing NES PRPS 
quality management arrangements.  
 
There was broad agreement that the modular pre-registration programme provided a 
useful building block for EL. However there were mixed views about the benefits of 
providing most of the EL in one year at the end, in two six month blocks or gradually 
dispersed across the course. One of the Schools was concerned about what would 
have to come out of the curriculum to accommodate EL however representatives 
from the service saw the opportunities already emerging from the elective options 
selected by students on the first cohort of the modular programme and that the 
matter of how to accommodate this across a five-year MPharm was a practical issue 
that should be addressed in the transition and implementation phases.  
 
The educational argument reinforced the value of closely aligning learning with the 
placement experience. There was some discussion about using holiday periods for 
EL however this may disadvantage students if it was unpaid as it reduced students’ 
ability to generate income to subsidise their study funding. There was some 
21 
evidence from a five-year MPharm degree which included two six-months blocks of 
pre-registration training that demonstrated that the students tended to fare less well 
in the earlier block but much better in the second six-month block when they were 
much more confident and able. Members felt that this provided a helpful reassurance 
to proposed changes to the existing model.  
There was a view from some members of the group that this might fundamentally 
change how pharmacists perceived placements provision as most wouldn’t see 
themselves as academics or an extension of the university. This most likely would 
require a change in mindset. There were lessons to be learnt from the experience of 
existing integrated courses and the balance of education and the timing of 
experience in practice to contextualise learning. There was also evidence of 
pedagogic benefits when the educational outcomes and EL experience were 
properly aligned and delivered by training providers who were motivated and 
enthusiastic. This was supported by evidence from the initial pre-registration student 
survey which identified that pharmacists who had been tutors for less than ten years 
were more self-critical and more driven to improve the training they provided.  
The Advisory Group heard evidence of the increase in preferences to cross-sector 
and portfolio working and agreed that this was likely to further accelerate. Overall 
there was agreement that a more dispersed model for EL allowed students to be 
exposed to different experiences across the time period and should be deliverable 
with the right planning and preparation.  
 Quality management
All Advisory Group members agreed that the existing NES PRPS quality 
management system would be the obvious starting point for any new arrangements 
that may be required. A comprehensive network of accredited training sites and a 
cohort of experienced tutors were already in place across Scotland. The existing 
principles of the quality management system could easily be extended to cover 
either an enhanced 4+1-year model or an integrated five-year model. Work would be 
required to scope and agree how NES, the two Schools and the service worked 
together to deliver any new arrangements. In addition, there were other systems in 
NES such as the nursing system that the group had learnt about that could be 
adapted to underpin any new measures.    
 Funding
At the outset of the work programme Advisory Group members had been informed 
that any recommendations needed to be implemented from within current available 
Scottish Government and Scottish Funding Council (SFC) funding envelopes in 
order to remain cost neutral. The SFC provides funding for an MPharm 
undergraduate degree as a science/laboratory-based subject at price group 2 
(£9,336 per FTE), unlike medicine and dentistry, who are funded for two years at 
price group 3 (£8,274 per FTE) and three years at price group 1 (£16,454 per FTE). 
Additional funding for experiential learning and placements for medical and dental 
undergraduate education comes through ACT funding. There is no equivalent for 
pharmacy meaning that opportunities for patient contact, placement and other forms 
of experiential learning are limited and rely on goodwill and personal relationships. 
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Currently the NHS PRPS scheme resources are almost fully directed towards the 
employment of 170 pre-registration pharmacists who are employed in Scotland by 
their preferred NES approved training provider and their salary and associated costs 
are covered by a training grant paid to the employer by NES. Members agreed that, 
notwithstanding some concerns about the lack of any new funding, something 
significantly better could be done with the existing PRPS money. There was some 
discussion about moving from the traditional science funding.  
 
 International students  
 
The matter of international students had been raised on a number of occasions. Both 
GPhC and the two Schools advised that the pre-registration training requirements for 
international students varied: some wanted a UK pre-registration training post, others 
wanted to go home after they had completed the undergraduate MPharm course. 
The Group had heard evidence from international students about the appeal of a 
fully integrated five-year MPharm. They had also learnt about the charging system 
for international students used by medicine and dentistry and also in the five-year 
MPharm pilots in England. There was a view expressed about selling a future vision 
on the value and desirability of having a Scottish five-year integrated MPharm 
qualification.  
 
 Admissions 
 
The Advisory Group heard that it was likely that the GPhC’s new initial education 
standards would include a requirement to interview prior to admission. Members 
agreed that values-based recruitment was used across the NHS and it would be a 
natural extension to introduce it at undergraduate level in both Schools. Members 
had heard about the use of multiple mini-interviews in medicine and in pharmacy and 
the evidence for such an approach. They acknowledged that including interviews in 
the admission process may require some alterations to UCAS deadlines however 
this wasn’t seen as a problem. The issue of poorly performing students was 
discussed including strategies to identify and support them sooner in the process, 
alongside existing university exit strategies. It was agreed that an improved 
admissions process would help identify some potentially unsuitable students before 
entry to the course. Following on from the Once for Scotland approach, the Advisory 
Group supported a single overarching process that was institutionally determined in 
order to maintain the Schools’ individual identities. 
 
Recommendations  
 
The Advisory Group members acknowledged the overwhelming impression that 
people wanted to see positive change. It wasn't that there was anything wrong with 
existing 4+1 model however there was a need to keep evolving and improving. 
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The model 
The consensus view from the advisory group was to recommend progressing to a 
five-year integrated initial education programme for pharmacists in Scotland. It 
was the view of the group that this provided opportunities to better prepare new 
pharmacists for practice in Scotland and permitted better management of pharmacy 
trainee numbers to meet workforce demands both in terms of initial recruitment and 
on-going progression. This, in turn, supported Ministerial priorities to strengthen the 
workforce, especially in primary care. It also supported the aim that every GP 
practice will have access to a pharmacist with advanced clinical skills as detailed in 
the recently published Health and Social Care Delivery Plan, by ensuring the new 
generation of pharmacists are able to practice in the evolving NHS health and social 
care landscape.  
However this decision was not unanimous and the two Heads of School from both 
universities asked for their concerns with regards the possible risks of implementing 
a five-year programme, with coterminous graduation and registration, including 
potential logistical problems such as resource availability and international student 
provision which were felt to outweigh any benefits, to be noted. That said, they both 
acknowledged that an evolution towards a five-year integrated MPharm over a ten 
year time frame was possible assuming there was due recognition of work to 
address the potential problem areas including a wholesale change of culture by the 
training providers. They did not, however, support a shortened journey stating a 
preference for good pilot studies, robust evidence for progression and apposite 
resourcing.  
The Group did not recommend how a five-year integrated model would be delivered 
(a 12 month block in year five; two six month blocks, the later in the final six months 
of year five; or a dispersed set of blocks across the first four years and a final six 
month block at the end of the fifth year). They agreed that this detail was better 
worked through as part of the implementation work programme.    
Advisory Group members also agreed that a Scotland-wide approach to introducing 
a new model was preferable in common with the Once for Scotland approach 
promoted by Scottish Government and the service. It could also support a regional 
accreditation approach going forward and this would help facilitate that from a 
Scotland perspective.  
In forming this decision, the following key issues and priorities were considered and 
will form the basis of transitional and implementation arrangements: 
 Funding: deliver within the existing funding envelope and utilise the current
funding arrangements more effectively.
 Numbers: agree and align student/trainee intake numbers including any
flexibility in trainee numbers based on workforce needs to ensure NHS
Scotland is self-sufficient and to provide for a progression based on merit.
 Attributes: ensure suitable attribute and qualities to meet workforce demands.
 Admissions: develop a standardised admissions process which is based on
values-based recruitment and includes multiple mini-interviews.
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 Experiential learning: increase experiential learning in the undergraduate
programmes to support preparation for practice. Embed clinical decision-
making and clinical assessment skills in the undergraduate MPharm. Increase
interprofessional learning.
 Training providers: increase the range of training providers utilised for both
MPharm experiential learning placements and pre-registration training, and
provide a quality management framework to ensure effective support. Ensure
the service supports experiential learning across hospital, community
pharmacy and primary care.
 Quality management: develop the existing quality management processes to
support the new arrangements as they are implemented.
 International students: ensure the model supports the two Schools of
Pharmacy to maintain and manage international students. .
Implementation outline 
It is proposed that the new five-year integrated initial education programme for 
pharmacists in Scotland could commence implementation from 2020-2021. The aim 
would be for the programme to provide coterminus graduation and registration. The 
first students achieving this status could graduate and register in summer 2025. This 
will require the two Schools of Pharmacy to apply for reaccreditation with the GPhC 
which could be aligned to happen within the same timescale (2019-2020). Between 
now and the introduction of the five-year integrated MPharm an enhanced 4+1 
model will provide a transitional programme structure. 
This proposal prepares for a managed integration of the 4-year MPharm and 1-year 
pre-registration training programmes, with progress to a fully integrated five-year 
programme determined by agreement with stakeholders and, in particular, students 
already enrolled in MPharm degrees in Scotland. The modular PRPS pilot will be 
rolled out across the transitional period providing experience in the three main 
patient-facing sectors of practice. 
A new funding model will be proposed for the transition period to support both 
trainees and training providers. Alongside this, improvements to the admissions 
process will mean that students who successfully complete their MPharm during the 
transition period will automatically progress, based on merit, to a NES pre-
registration position.    
Scottish Government, in collaboration with NES, the service and the two Schools of 
Pharmacy, will advise on student intake numbers and a values-based admissions 
process including multiple mini-interviews will be developed that will include the 
involvement of training providers in the selection of the student intake. The plan is to 
pilot the admissions process in 2018-2019 and roll out from 2019-2020. 
During the transitional phase students will still graduate at the end of the year four 
and then progress to their pre-registration year. Successful completion of the pre-
registration year will permit registration. However, students not wishing to progress 
to the pre-registration year may still graduate with an MPharm and can pursue pre-
registration training out with Scotland if that is desired. Likewise, international 
students can also graduate at this time.  
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Proposed actions and next steps 
 Agree proposal indicative timescales;
 Sign off transitional arrangements;
 Establish a series of working groups to consider: admissions and recruitment;
funding; programme development (including experiential learning and
interprofessional learning); and quality management and governance;
 Clarify position of international students including visa requirements; and
 Schools of Pharmacy to start planning towards accreditation of a five-year
integrated MPharm.
Pharmacy and Medicines Division 
Directorate of the Chief Medical Officer 
April 2017 
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Appendix 2 
FIVE YEAR INTEGRATED INITIAL EDUCATION PROGRAMME FOR 
PHARMACISTS IN SCOTLAND 
REMIT AND TERMS OF REFERENCE OF ADVISORY GROUP 
REMIT 
To advise the Chief Pharmaceutical Officer on options to evolve the existing 
pharmacist four-year undergraduate degree and the one-year pre-registration 
training scheme into an integrated five year programme to support the initial 
education of pharmacists in Scotland in response to current and future workforce 
developments.  
TERMS OF REFERENCE 
Aim 
To consider and agree a work plan for an integrated five year programme to support 
the initial education of pharmacists in Scotland. 
Objectives 
▪ To agree the remit and terms of reference of the advisory group
▪ To agree the timeline for the work plan of the advisory group
▪ To consider and advise on:
o Strengths and weaknesses of existing 4+1 MPharm model
o What an enhanced 4+1 MPharm model might look like
o Strengths and weaknesses of an integrated five-year MPharm
o What an integrated five-year MPharm might look like
o Barriers and facilitators to change
▪ To seek stakeholder views on draft proposals for a five year integrated initial
education programme for pharmacists in Scotland
▪ To consider any implementation implications
TIMESCALES 
The advisory group will report to the Chief Pharmaceutical Officer on the options by 
the end of November 2016 in order to inform plans going forward. 
Pharmacy and Medicines Division 
Directorate for Chief Medical Officer 
Scottish Government   
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Appendix 3 
 
FIVE YEAR INTEGRATED INITIAL EDUCATION PROGRAMME FOR PHARMACY WORK PLAN 
 
DATE EVENT OUTPUTS ACHIEVED 
Monday 
22nd 
August 
2016 
First Advisory Group 
Meeting 
 
- Short presentations from 
Schools of Pharmacy and 
NES 
 Consider and agree the Remit and Terms of Reference of the 
Group 
 Consider the membership of the group 
 Consider and agree the draft work plan 
 Identify any strengths and weaknesses of existing 4+1 model 
 Completed 22/08/16 
 BPSA & SFC to be invited 
 Agreed 22/08/16 
 Initial ideas captured 22/08/16 
 
 
Monday 
3rd  
October 
2016 
 
Second Advisory Group 
Meeting 
 
- Short presentations from 
NES medicine and 
nursing colleagues  
 Review progress on work plan 
 Consider how other healthcare professionals provide 
experiential and foundation training (medicine and nursing) 
 Explore what an enhanced 4+1 model might look like 
o Admissions 
o Placements 
o IPE 
o +1 component 
 Agree programme for stakeholder event 
 Completed 22/08/16 
 Medical and nursing models 
considered 
 Carried forward to next 
meeting 
 
 
 
 
 Completed 05/10/16 
 
Monday 
10th  
October 
2016 
 
 
Stakeholder event 
 Gauge stakeholders views on draft proposals for a five year 
integrated initial education programme for pharmacists in 
Scotland  
o Enhanced 4+1 
o Integrated five-year 
o Timescales 
o Next steps 
 Completed and report 
circulated for comment 
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Monday 
21st 
November 
2016 
Third Advisory Group 
Meeting 
- Short presentation from
Nottingham University
 Review progress on work plan
 Consider the strengths and weaknesses of an integrated five-
year MPharm
 Explore what an enhanced 4+1 model might look like
o Admissions
o Placements
o IPE
o +1 component
 Explore what an integrated five-year MPharm might look like
 Consider the barriers and facilitators to change
o Regulations
o Funding
o Buy-in
o Capacity
o Assessment
 Completed on 21/11/16
 Discussed 21/11/16 and
carried forward
 Discussed and carried forward
 Carried forward to 05/12/16
 Carried forward to 05/12/16
Monday 
5th 
December 
2016 
Final Advisory Group 
Meeting 
- Short presentation from
NES on main outputs from
the work
 Review progress on work plan
 Review and agree draft report
 Consider any implementation implications
 Completed on 05/12/16
 Completed 05/12/16
 Completed 05/12/16
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